Brief: Ramm Pharma Enters European Cannabis Market With Strategic Investment In Canapar Corp.
30/12/2020 22:29
Ramm Pharma Corp RAMM.CD :
* RAMM PHARMA ENTERS EUROPEAN CANNABIS MARKET WITH STRATEGIC
INVESTMENT IN CANAPAR CORP.
* RAMM PHARMA - HAS ACQUIRED 49% OF CANAPAR CORP.
Source text for Eikon: ID:nGNX7R85PZ
Further company coverage: RAMM.CD
Recent news on Ramm Pharma
See all newsBrief: Ramm Pharma Corp Announces Non-Brokered Private Placement And Intention To Commence Normal Course Issuer Bid
Brief: RAMM Pharma Initiates Clinical Trials Of Its Proprietary Nettavet Cannabinoid Formulation
Brief: Ramm Pharma Enters European Cannabis Market With Strategic Investment In Canapar Corp.